Movement Alert|Corteva, Inc. Falls 3.02% in Regular Trading, BMO Target Price Cut Compounds Sector-Wide Weakness

Market Focus09-17

On September 17, Corteva, Inc. fell 3.02% in regular trading, trading at $80.78 per share, with turnover of $297 million. The decline was driven by a combination of an analyst target price reduction and broad-based selling across the fertilizers and agricultural chemicals sector.

BMO Capital Markets lowered its price target on Corteva, Inc. to $95 from $100 while maintaining its Outperform rating. The adjustment came shortly after the company's investor day, where its board formally approved the separation of its seed business into an independent publicly traded company named Vylor through a pro rata stock dividend, with completion targeted for October 1. RBC Capital Markets maintained a more constructive view, keeping a $103 target and noting Vylor management expects 3%-4% annual sales growth and 7%-8% annual EBITDA growth through 2029.

Meanwhile, the broader agricultural chemicals sector faced significant headwinds. FMC Corp declined 5.38%, Mosaic fell 3.17%, CF Industries Holdings dropped 2.45%, Scotts Miracle-Gro lost 2.09%, and Nutrien slipped 1.77%, amplifying downward pressure on Corteva, Inc.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment